Triple

T2190687
Position Surface form Disambiguated ID Type / Status
Subject Xarelto E49852 entity
Predicate hasAntidote P4524 FINISHED
Object andexanet alfa
Andexanet alfa is a recombinant modified human factor Xa protein used as a reversal agent to counteract the anticoagulant effects of factor Xa inhibitors such as rivaroxaban and apixaban.
E241384 NE FINISHED

How this triple was built (5 steps)

Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.

NER Named-entity recognition gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: andexanet alfa | Statement: [Xarelto, hasAntidote, andexanet alfa]
NED1 Entity disambiguation (via context triple) gpt-5-mini-2025-08-07
Target entity: andexanet alfa
Context triple: [Xarelto, hasAntidote, andexanet alfa]
  • A. Anif
    Anif is a small Austrian municipality near Salzburg, known for its historic castle and as a residence of notable figures.
  • B. Enyo
    Enyo is a Greek goddess of war and destruction, often depicted as a close companion and counterpart to the war god Ares.
  • C. Alpha
    Alpha is the first letter of the Greek alphabet, often symbolizing beginnings, primacy, or the starting point in various contexts.
  • D. Alpha
    Alpha is Sony’s line of interchangeable-lens mirrorless and DSLR-style digital cameras aimed at photography enthusiasts and professionals.
  • E. ANA
    ANA is the standard three-letter abbreviation used for the Anaheim Ducks, a professional ice hockey team in the National Hockey League.
  • F. None of above. chosen
  • G. Unsure - the case is ambiguous/there is not enough information to decide.
NEDg Description generation gpt-5.1
Instruction
Generate a one-sentence description of the target entity. 
You are given a context triple in the form (subject, predicate, object), where the object is the target entity. 
# Instructions
Use the triple to infer relevant information about the entity. Describe the entity based on what is most defining, well-known. 
Avoid repeating the information from the triple, unless really essential.
# Response Format
Return only the sentence: "Description: [one-sentence description of the target entity]"
Input
Entity: andexanet alfa
Triple: [Xarelto, hasAntidote, andexanet alfa]
Generated description
Andexanet alfa is a recombinant modified human factor Xa protein used as a reversal agent to counteract the anticoagulant effects of factor Xa inhibitors such as rivaroxaban and apixaban.
NED2 Entity disambiguation (via description) gpt-5-mini-2025-08-07
Target entity: andexanet alfa
Target entity description: Andexanet alfa is a recombinant modified human factor Xa protein used as a reversal agent to counteract the anticoagulant effects of factor Xa inhibitors such as rivaroxaban and apixaban.
  • A. Anif
    Anif is a small Austrian municipality near Salzburg, known for its historic castle and as a residence of notable figures.
  • B. Enyo
    Enyo is a Greek goddess of war and destruction, often depicted as a close companion and counterpart to the war god Ares.
  • C. Alpha
    Alpha is the first letter of the Greek alphabet, often symbolizing beginnings, primacy, or the starting point in various contexts.
  • D. Alpha
    Alpha is Sony’s line of interchangeable-lens mirrorless and DSLR-style digital cameras aimed at photography enthusiasts and professionals.
  • E. ANA
    ANA is the standard three-letter abbreviation used for the Anaheim Ducks, a professional ice hockey team in the National Hockey League.
  • F. None of above. chosen
PD Predicate disambiguation gpt-5-mini-2025-08-07
Target predicate: hasAntidote
Context triple: [Xarelto, hasAntidote, andexanet alfa]
  • A. hasNotableDrug
    Indicates that an entity is associated with a drug that is considered notable or significant in some recognized context.
  • B. shieldTincture
    Indicates the heraldic color, pattern, or material applied to the surface of a shield.
  • C. hasPower
    Indicates that one entity possesses authority, control, or influence over another entity or over a particular domain or resource.
  • D. supporterTincture
    Indicates that a heraldic supporter (a figure holding or standing beside the shield) bears a specified tincture (color or pattern).
  • E. remedy chosen
    Indicates that one entity serves to cure, alleviate, or counteract a problem, illness, or undesirable condition affecting another entity.
  • F. None of above.

Provenance (6 batches)

The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.

Step Stage Batch ID Status When
creating Elicitation batch_69a88aaba3c48190b351cab9b26989ff completed March 4, 2026, 7:40 p.m.
NER Named-entity recognition batch_69abbf9e99f08190892d34485c8f2f25 completed March 7, 2026, 6:03 a.m.
NED1 Entity disambiguation (via context triple) batch_69ae5db0352c8190aa9c4c58460df3a4 completed March 9, 2026, 5:42 a.m.
NEDg Description generation batch_69ae5e60b45c819088bf18ae564f0d1a completed March 9, 2026, 5:45 a.m.
NED2 Entity disambiguation (via description) batch_69ae5ec4a35c8190bffc7a183497e764 completed March 9, 2026, 5:46 a.m.
PD Predicate disambiguation batch_69abbda32d1881909d1fd83a751fb21c completed March 7, 2026, 5:54 a.m.
Created at: March 4, 2026, 7:46 p.m.